Nadolol and bendroflumethiazide vs Calcium Channel Blockers (Nondihydropyridine)

Interacting Drugs
Nadolol and bendroflumethiazide
vs
Calcium Channel Blockers (Nondihydropyridine)
Security Level
Minor, Monitor Therapy
Mechanism
Calcium Channel Blockers (Nondihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers. Exceptions: Bepridil [Off Market].
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Nadolol and bendroflumethiazide vs Calcium Channel Blockers (Nondihydropyridine)